ConductScience.org, home

Paper17522949

The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.

Miesbach W and 7 others. Clin Rheumatol, 2007. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome. Papers, record 17522949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17522949

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.
PubMed
Journal
Clin Rheumatol
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2026-10-11
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miesbach WW
2Asherson RAR A
3Cervera RR
4Shoenfeld YY
5Puerta JGJ Gomez
6Espinosa GG
7Bucciarelli SS
8Members of the CAPS Registry GroupGroup

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiphospholipid SyndromeMajor topic
NeoplasmsMajor topic
Adolescent
Adult
Aged
Anticoagulants
Child
Female
Glucocorticoids
Humans
Immunosuppressive Agents
Incidence
Male
Middle Aged
Plasma Exchange
Prognosis
Renal Dialysis
Retrospective Studies
Risk Factors

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111426612The significance of autoantibodies in non-Hodgkin's lymphoma.Leuk Lymphoma2000https://conductscience.org/library/papers/11426612PubMed
212630755High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis.Lupus2003https://conductscience.org/library/papers/12630755PubMed
311590582Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases.Semin Arthritis Rheum2001https://conductscience.org/library/papers/11590582PubMed
412892393Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.Lupus2003https://conductscience.org/library/papers/12892393PubMed
57640230Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.Br J Cancer1995https://conductscience.org/library/papers/7640230PubMed
616547696"Primary" antiphospholipid syndrome evolving into Waldenstrom's macroglobulinaemia: a case report.Clin Rheumatol2007https://conductscience.org/library/papers/16547696PubMed
712038453Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma.Eur J Haematol2002https://conductscience.org/library/papers/12038453PubMed
811704713Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients.Medicine (Baltimore)2001https://conductscience.org/library/papers/11704713PubMed
915708888Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.Ann Rheum Dis2005https://conductscience.org/library/papers/15708888PubMed
1010968896Antiphospholipid antibodies, malignancies and paraproteinemias.J Autoimmun2000https://conductscience.org/library/papers/10968896PubMed
1116721493High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma.Clin Rheumatol2007https://conductscience.org/library/papers/16721493PubMed
1215297851Antiphospholipid antibodies in lymphoma: prevalence and clinical significance.Hematol J2004https://conductscience.org/library/papers/15297851PubMed
1314593307The catastrophic antiphospholipid syndrome--Asherson's syndrome.Ann Med Interne (Paris)2003https://conductscience.org/library/papers/14593307PubMed
1415361392Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.Ann Rheum Dis2004https://conductscience.org/library/papers/15361392PubMed
1510996834Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS).Am J Hematol2000https://conductscience.org/library/papers/10996834PubMed
1612759289Long term outcome of catastrophic antiphospholipid syndrome survivors.Ann Rheum Dis2003https://conductscience.org/library/papers/12759289PubMed
178115979Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma.Thromb Haemost1993https://conductscience.org/library/papers/8115979PubMed
187988947A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study.Haemostasis1994https://conductscience.org/library/papers/7988947PubMed
1916466624The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy.Clin Exp Rheumatol2006https://conductscience.org/library/papers/16466624PubMed
2016868979Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.Arthritis Rheum2006https://conductscience.org/library/papers/16868979PubMed

See all 24 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
41299702Catastrophic antiphospholipid syndrome following surgery for Libman-Sacks endocarditis: A case report and literature review.J Cardiothorac Surg2025https://conductscience.org/library/papers/41299702PubMed
36662720Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.PLoS One2023https://conductscience.org/library/papers/36662720PubMed
35847716Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review.EJHaem2020https://conductscience.org/library/papers/35847716PubMed
31583137The Conundrum of Septic Shock Imitators in Patients with Hematologic Cancers: Case Presentation and Possible Differential Diagnoses.Case Rep Crit Care2019https://conductscience.org/library/papers/31583137PubMed
26927441Treatment of catastrophic antiphospholipid syndrome.Curr Opin Rheumatol2016https://conductscience.org/library/papers/26927441PubMed
22203433The future of autoimmunity.Clin Rev Allergy Immunol2012https://conductscience.org/library/papers/22203433PubMed
20425537Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome.Curr Rheumatol Rep2010https://conductscience.org/library/papers/20425537PubMed
19048416Malignancies and catastrophic anti-phospholipid syndrome.Clin Rev Allergy Immunol2009https://conductscience.org/library/papers/19048416PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17522949

GET https://conductscience.org/api/papers/v1/17522949/references?page=2